Cullinan Therapeutics (CGEM) Enterprise Value (2021 - 2026)
Cullinan Therapeutics (CGEM) recorded Enterprise Value of $837.24 million in Q2 2026, up 366.9% from $179.33 million a year earlier and up 60.6% from the prior quarter.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Enterprise Value (2021 - 2026) Analysis & Trends
For FY2025, Cullinan Therapeutics reported Enterprise Value of $245.63 million, down 21.7% from FY2024.
- Annual Enterprise Value has a four-year compound annual growth rate of -11.1% (FY2021 to FY2025).
- Across earlier years, Enterprise Value came in at $313.66 million in FY2024, -$29.72 million in FY2023, $15.86 million in FY2022 (-96.0%) and $393.36 million in FY2021.
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q1 2021.
- On a year-over-year basis, Enterprise Value rose in two of the last six quarters, with growth averaging 69.8%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 366.9% in Q2 2026, against a decline of 98.4% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $521.32 million (Q1 2026), $245.63 million (Q4 2025) and $17.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Cullinan Therapeutics | 722.60 Mn | -1.13 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 698.13 Mn |
| Jun 30, 2026 | 837.24 Mn |
| Mar 31, 2026 | 521.32 Mn |
| Dec 31, 2025 | 245.63 Mn |
| Sep 30, 2025 | 17.72 Mn |
| Jun 30, 2025 | 179.33 Mn |
| Mar 31, 2025 | 140.55 Mn |
| Dec 31, 2024 | 313.66 Mn |
| Sep 30, 2024 | 395.18 Mn |
| Jun 30, 2024 | 346.79 Mn |
| Mar 31, 2024 | 300.83 Mn |
| Dec 31, 2023 | -29.72 Mn |
| Sep 30, 2023 | 335.36 Mn |
| Jun 30, 2023 | -31.97 Mn |
| Mar 31, 2023 | 11.79 Mn |
| Dec 31, 2022 | 15.86 Mn |
| Sep 30, 2022 | 10.47 Mn |
| Jun 30, 2022 | -28.93 Mn |
| Mar 31, 2022 | 153.50 Mn |
| Dec 31, 2021 | 393.36 Mn |
API Access
Cullinan Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CGEM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();